A Metrology Informatics Investigation of Conversion Therapy in Hepatocellular Carcinoma: 2014–2023
This study highlights key contributors and emerging trends and provides important predictions for future research directions. To achieve effective conversion therapy for HCC, researchers may prioritize immunotherapy and locoregional treatments such as hepatic arterial infusion chemotherapy or radioembolization.
Authors
- Xiongying Jiang (ORCID: https://orcid.org/0000-0003-4488-9326)
- Ming Zhao (ORCID: https://orcid.org/0000-0002-1025-8895)
- Qifeng Chen (ORCID: https://orcid.org/0000-0001-8998-3450)
- Ning Lyu (ORCID: https://orcid.org/0000-0002-8254-1040)
- Minshan Chen (ORCID: https://orcid.org/0000-0002-6116-5015)
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Annals of Surgery Open
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1097/as9.0000000000000562
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00